INTRODUCTION
neuroblastoma
NEUROBLASTOMA, METASTATIC DISEASE
Patients with high-risk neuroblastoma (HR-NB) have 5-year survival rates of approximately 50%, whereas patients with metastatic disease at relapse show a 4-year progression-free survival of 6% and overall survival (OS) of 15%.